Drug recall · January 22, 2025
Cardura XL recall
Why: Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93
- Lots / codes
Lot# 8182298, Exp 10/31/2025
- Quantity
- 6,605/30 count bottles
- Company
- Viatris Inc, Canonsburg, PA
- Distribution
- USA nationwide.
- Initiated
- December 23, 2024 · Voluntary: Firm initiated
- Classified
- January 16, 2025
- Reported
- January 22, 2025
- Ended
- November 12, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cardura
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.